HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Martínez Selected Research

dorzolamide (Trusopt)

8/2010Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
6/2009A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients.
6/2008Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
3/2007Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides.
1/2006A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Martínez Research Topics

Disease

14Neoplasms (Cancer)
12/2021 - 07/2002
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 11/2002
6Breast Neoplasms (Breast Cancer)
12/2015 - 10/2002
4Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2010 - 01/2006
3Rheumatoid Arthritis
09/2021 - 08/2011
3Rheumatic Diseases (Rheumatism)
09/2021 - 10/2015
3Neoplasm Metastasis (Metastasis)
08/2011 - 10/2002
3Lymphoma (Lymphomas)
11/2010 - 12/2002
3Carcinoma (Carcinomatosis)
03/2008 - 01/2005
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2021 - 01/2014
2Ankylosing Spondylitis
09/2021 - 06/2014
2Crohn Disease (Crohn's Disease)
01/2019 - 04/2016
2Disease Progression
01/2019 - 01/2019
2Hypertension (High Blood Pressure)
12/2015 - 10/2003
2Thrombosis (Thrombus)
03/2012 - 01/2007
2Brain Neoplasms (Brain Tumor)
08/2011 - 03/2008
2Multiple Sclerosis
06/2010 - 12/2009
2Glaucoma
03/2007 - 01/2006
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
10/2006 - 07/2005
2Urinary Bladder Neoplasms (Bladder Cancer)
09/2005 - 01/2005
1Communicable Diseases (Infectious Diseases)
12/2021
1Psoriatic Arthritis
09/2021
1Human Influenza (Influenza)
08/2021
1Porcine Reproductive and Respiratory Syndrome (PRRS)
08/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018
1Multiple Myeloma
10/2017
1Genomic Instability
07/2016
1Hypertriglyceridemia
03/2016
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
12/2015
1Ataxia (Dyssynergia)
11/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2013
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2013
1Malaria
01/2013
1Myocardial Infarction
03/2012
1Death (Near-Death Experience)
03/2012
1Cardiovascular Diseases (Cardiovascular Disease)
03/2012
1Lymphadenopathy
12/2011
1Weight Loss (Weight Reduction)
12/2011
1Fever (Fevers)
12/2011

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2019 - 10/2002
8Biological ProductsIBA
12/2021 - 03/2008
8Pharmaceutical PreparationsIBA
09/2021 - 01/2006
5DNA (Deoxyribonucleic Acid)IBA
12/2015 - 07/2005
5Timolol (Blocadren)FDA LinkGeneric
08/2010 - 01/2006
5dorzolamide (Trusopt)FDA LinkGeneric
08/2010 - 01/2006
4Infliximab (Remicade)FDA Link
01/2019 - 08/2011
3AntibodiesIBA
08/2021 - 09/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 06/2014
3Rituximab (Mabthera)FDA Link
01/2019 - 07/2010
3Cyclin D1IBA
01/2014 - 07/2002
2Adalimumab (Humira)FDA Link
09/2021 - 01/2019
2CPI203IBA
01/2019 - 10/2017
2Protein Isoforms (Isoforms)IBA
01/2018 - 07/2006
2Transcription Factors (Transcription Factor)IBA
10/2017 - 03/2011
2Lenalidomide (CC 5013)FDA Link
10/2017 - 01/2014
2Biomarkers (Surrogate Marker)IBA
12/2015 - 07/2006
2ChromatinIBA
11/2013 - 11/2003
2ElementsIBA
11/2010 - 11/2003
2OligonucleotidesIBA
08/2010 - 02/2007
2brinzolamide (Azopt)FDA Link
08/2010 - 06/2009
2EnzymesIBA
02/2010 - 09/2005
2Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
09/2005 - 01/2005
2Messenger RNA (mRNA)IBA
01/2005 - 12/2002
1CD40 Ligand (CD40L)IBA
12/2021
1C-Reactive ProteinIBA
01/2019
1AlbuminsIBA
01/2019
1CytokinesIBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1Ustekinumab (CNTO 1275)FDA Link
01/2019
1Chemokine ReceptorsIBA
01/2019
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2019
1CT-P13IBA
01/2018
1Biosimilar PharmaceuticalsIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
10/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2017
1Immunomodulating AgentsIBA
10/2017
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1Bacterial DNAIBA
04/2016
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
03/2016
1LipidsIBA
03/2016
1Angiogenesis InhibitorsIBA
12/2015
1Bevacizumab (Avastin)FDA Link
12/2015
1golimumabFDA Link
10/2015
1Methotrexate (Mexate)FDA LinkGeneric
09/2015
1Tumor Necrosis Factor InhibitorsIBA
06/2014
1Toll-Like Receptor 2IBA
11/2013
1Apoptosis Regulatory ProteinsIBA
11/2013
1omega-Chloroacetophenone (Mace)IBA
03/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2011
1Inhibins (Inhibin)IBA
08/2011
1glucose-regulated proteinsIBA
08/2011

Therapy/Procedure

8Therapeutics
12/2021 - 10/2002
6Drug Therapy (Chemotherapy)
01/2019 - 10/2002
2Prostatectomy (Retropubic Prostatectomy)
04/2013 - 08/2010
1Stents
03/2012